Investor Center
AMAG Pharmaceuticals, Inc. provides corporate information on our Web Site. learn more…
21.94
Last
-0.46 -2.09%
AMAG currently markets an intravenous iron in the United States for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD). AMAG is seeking to expand its portfolio with additional commercial-stage specialty pharmaceuticals that leverage the company's commercial footprint.
AMAG Pharmaceuticals, Inc. 2012 Form 10K and 2013 Proxy Materials Available |
|
| 2012 Form 10K | 2013 Annual Shareholders Meeting Materials |